Pharma Mar, S.A.
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
44.7584.04-24.82-21.20-43.51-86.039.4611.0923.51664.672.26K-43.51
Price/Sales ratio
3.942.873.303.161.489.204.814.485.914.778.371.48
Price/Book Value ratio
9.187.2011.4121.1011.2669.4412.645.795.203.907.7369.44
Price/Cash Flow ratio
26.5549.87-71.04-388.71-14.73-30.214.6540.1230.28-56.20854.18-14.73
Price/Free Cash Flow ratio
49.20294.49-41.20-92.60-12.86-26.284.7057.6439.38-25.70-79.12-26.28
Price/Earnings Growth ratio
2.23-1.680.05-1.980.54-1.29-0.00-0.35-0.50-6.8078.590.54
Dividend Yield
5.29%6.29%3.36%3.51%N/AN/A0.67%1.05%1.01%1.54%0.81%N/A
Profitability Indicator Ratios
Gross Profit Margin
76.60%76.29%75.69%74.53%77.88%93.90%94.91%92.84%93.05%93.92%94.41%77.88%
Operating Profit Margin
13.61%5.87%-10.33%-9.85%-8.67%-20.36%57.76%40.22%22.44%-2.41%-2.82%-8.67%
Pretax Profit Margin
9.73%3.11%-13.65%-12.74%-11.53%-25.23%53.93%41.39%22.30%-2.29%-2.41%-11.53%
Net Profit Margin
8.82%3.41%-13.30%-14.91%-3.41%-10.69%50.84%40.40%25.13%0.71%0.37%-3.41%
Effective Tax Rate
9.00%-10.89%2.39%-17.07%13.36%57.60%5.73%2.38%-12.71%131.38%115.42%13.36%
Return on Assets
6.51%3.10%-10.89%-14.24%-3.51%-7.36%41.56%25.20%12.55%0.33%0.18%-3.51%
Return On Equity
20.53%8.56%-45.99%-99.54%-25.89%-80.71%133.62%52.19%22.13%0.58%0.33%-25.89%
Return on Capital Employed
17.03%8.01%-13.96%-16.90%-16.49%-27.19%66.26%32.77%14.89%-1.56%-1.93%-16.49%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.66N/A
Quick Ratio
0.931.261.130.830.750.672.463.292.542.222.120.75
Cash ratio
0.200.100.160.280.310.291.011.311.530.620.380.31
Days of Sales Outstanding
88.9074.79124.7863.8853.0056.3236.11125.3154.5163.5973.6453.00
Days of Inventory outstanding
256.06183.59183.93191.05209.80621.50317.50233.96742.521.49K1.87K209.80
Operating Cycle
344.97258.39308.71254.93262.80677.82353.61359.27797.031.55K1.94K262.80
Days of Payables Outstanding
273.54246.60304.74286.37317.831.14K559.79597.96735.721.10K1.37K317.83
Cash Conversion Cycle
71.4211.783.97-31.43-55.02-472.12-206.17-238.6861.31447.65565.46-55.02
Debt Ratios
Debt Ratio
0.450.440.430.530.590.660.160.120.090.110.100.66
Debt Equity Ratio
1.421.211.823.714.377.270.510.250.170.200.197.27
Long-term Debt to Capitalization
0.420.450.560.730.750.820.260.150.100.120.120.82
Total Debt to Capitalization
0.580.540.640.780.810.870.340.200.140.170.160.87
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.60N/A
Cash Flow to Debt Ratio
0.240.11-0.08-0.01-0.17-0.315.250.560.98-0.330.04-0.17
Company Equity Multiplier
3.152.754.226.987.3710.963.212.071.761.761.8210.96
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.140.05-0.04-0.00-0.10-0.301.030.110.19-0.080.00-0.10
Free Cash Flow / Operating Cash Flow Ratio
0.530.161.724.191.141.140.980.690.762.18-10.711.14
Cash Flow Coverage Ratio
0.240.11-0.08-0.01-0.17-0.315.250.560.98-0.330.04-0.17
Short Term Coverage Ratio
0.490.38-0.30-0.05-0.57-0.8818.212.102.91-1.040.16-0.57
Dividend Payout Ratio
236.88%529.25%-83.63%-74.57%N/AN/A6.42%11.70%23.82%1028.05%1836.01%N/A